What is it about?
Understanding how a precise immunological risk assessment can help select target levels of immunosuppression
Featured Image
Why is it important?
Ideal target levels for tacrolimus are not known. In order to personalize the care of renal transplant patients one must have a precise measure of the immunologic risk.
Perspectives
I hope this article with help clinicians make more informed decisions when selecting immunosuppression targets for their renal transplant patients
Chris Wiebe
University of Manitoba
Read the Original
This page is a summary of: Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development, Journal of the American Society of Nephrology, July 2017, American Society of Nephrology,
DOI: 10.1681/asn.2017030287.
You can read the full text:
Contributors
The following have contributed to this page
